FDA Drug Application (204119) for EFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE by HETERO DRUGS LTD

Back to FDA Applications sponsored by HETERO DRUGS LTD

Application Number204119
Product Number001
FormTABLET; ORAL
Dosage600MG;300MG;300MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE
Active IngredientEFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE



Back to FDA Applications sponsored by HETERO DRUGS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.